Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) Short Interest Update

Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP) saw a large decline in short interest during the month of March. As of March 31st, there was short interest totalling 1,555,700 shares, a decline of 7.7% from the March 15th total of 1,684,700 shares. Based on an average daily trading volume, of 1,083,800 shares, the days-to-cover ratio is presently 1.4 days.

Elite Pharmaceuticals Stock Up 3.7 %

ELTP opened at $0.14 on Wednesday. The company has a market cap of $149.56 million, a P/E ratio of 14.01 and a beta of -0.16. Elite Pharmaceuticals has a 12 month low of $0.03 and a 12 month high of $0.21. The business’s 50-day moving average price is $0.16 and its 200-day moving average price is $0.15. The company has a current ratio of 1.94, a quick ratio of 1.19 and a debt-to-equity ratio of 0.08.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.